draflazine has been researched along with pd 81723 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belardinelli, L; Bruns, RF; Dennis, D; Kollias-Baker, C; Linden, J; Ruble, J | 1 |
| Belardinelli, L; Kollias-Baker, C; Pelleg, A; Xu, J | 1 |
| Belardinelli, L; Dennis, DM; Martens, JR; Raatikainen, MJ | 1 |
3 other study(ies) available for draflazine and pd 81723
| Article | Year |
|---|---|
Allosteric enhancer PD 81,723 acts by novel mechanism to potentiate cardiac actions of adenosine.
Topics: Adenosine; Allosteric Regulation; Animals; Binding Sites; Brain; Bundle of His; Drug Synergism; Female; Guinea Pigs; Heart; Humans; In Vitro Techniques; Male; Membranes; Myocardium; Piperazines; Radioligand Assay; Receptors, Purinergic P1; Thiophenes | 1994 |
Novel approach for enhancing atrioventricular nodal conduction delay mediated by endogenous adenosine.
Topics: Adenosine; Animals; Atrioventricular Node; Bundle of His; Coronary Vessels; Female; Guinea Pigs; Hypoxia; In Vitro Techniques; Male; Piperazines; Receptors, Purinergic P1; Thiophenes; Tubercidin; Vasodilation | 1994 |
Modulation of atrioventricular nodal function by metabolic and allosteric regulators of endogenous adenosine in guinea pig heart.
Topics: Adenosine; Allosteric Regulation; Animals; Atrioventricular Node; Biological Transport; Body Fluids; Enzyme Inhibitors; Guinea Pigs; Heart; Heart Conduction System; In Vitro Techniques; Myocardium; Nucleosides; Pericardium; Piperazines; Platelet Aggregation Inhibitors; Thiophenes; Tubercidin | 1996 |